Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms
Susann Winter(University Hospital Carl Gustav Carus), Shahram Kordasti(Guy's Hospital), Uta Oelschlaegel(University Hospital Carl Gustav Carus), M. Schneider, Desmond Choy(King's College London), Jessica A. Timms(King's College London), Sara Bencini(University of Florence), Esther Güse(Friedrich-Alexander-Universität Erlangen-Nürnberg), Rita Antunes Dos Reis(Guy's Hospital), Marco Gabriele Raddi(Azienda Ospedaliero-Universitaria Careggi), Julio Vera(Universidad de La Laguna), Antje Tunger(Helmholtz-Zentrum Dresden-Rossendorf), Benedetta Peruzzi, Katja Sockel(Innsbruck Medical University), Marc Schmitz(Berlin-Brandenburger Centrum für Regenerative Therapien), Uwe Platzbecker(National Center for Tumor Diseases), Christopher Lischer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Giulia Maggioni(Humanitas University), Antonella Poloni(Marche Polytechnic University), Matteo Giovanni Della Porta(Humanitas University), Elena Riva(Humanitas University), Valeria Santini(Azienda Ospedaliero-Universitaria Careggi), Nicolas Sompairac(Inserm)
Cited by 7
Related Papers
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0
|Nature Protocols|2019|1.4k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k